CapVest Partners acquiring €10bn pharma group STADA Arzneimittel
tags: Bain| CapVest| Cinven| healthcare| M&A| pharma| pharmaceutical| private market deals| STADA Arzneimittel
European investment firm CapVest Partners has secured a definitive agreement to acquire a majority (70%) stake in STADA Arzneimittel AG from private equity firms Bain Capital and Cinven, valuing the German pharmaceutical giant at approximately €10bn including debt. The transaction positions CapVest as the new controlling shareholder while Bain Capital and Cinven retain minority stakes after eight years of ownership, reflecting their continued confidence…